Bipolar and Related Disorders
11
2
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS
Implementing Action-Based Cognitive Remediation for Transdiagnostic Cognitive Difficulties in a Tertiary Mental Health Hospital
An Innovative Master Platform for Clinical Trials in Mood Disorders
Studying the Health of Asians to Advance Knowledge, Treatments, and Interventions for Depression
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling
A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar Illness
Ascertaining Diagnosis Classification With Elicited Speech
Enhancing Cognitive Reserve of the Offsprings of Bipolar and Schizophrenic Patients
Employment Outcomes After Vocational Training